JP2021534796A5 - - Google Patents
Info
- Publication number
- JP2021534796A5 JP2021534796A5 JP2021511541A JP2021511541A JP2021534796A5 JP 2021534796 A5 JP2021534796 A5 JP 2021534796A5 JP 2021511541 A JP2021511541 A JP 2021511541A JP 2021511541 A JP2021511541 A JP 2021511541A JP 2021534796 A5 JP2021534796 A5 JP 2021534796A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- vector
- shrna
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024081593A JP2024119830A (ja) | 2018-08-31 | 2024-05-20 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
| JP2025266930A JP2026067864A (ja) | 2018-08-31 | 2025-12-19 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726184P | 2018-08-31 | 2018-08-31 | |
| US62/726,184 | 2018-08-31 | ||
| US201862749622P | 2018-10-23 | 2018-10-23 | |
| US62/749,622 | 2018-10-23 | ||
| US201862754530P | 2018-11-01 | 2018-11-01 | |
| US62/754,530 | 2018-11-01 | ||
| PCT/US2019/049163 WO2020047476A1 (en) | 2018-08-31 | 2019-08-30 | Adeno-associated viral vectors for the treatment of best disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024081593A Division JP2024119830A (ja) | 2018-08-31 | 2024-05-20 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534796A JP2021534796A (ja) | 2021-12-16 |
| JP2021534796A5 true JP2021534796A5 (enExample) | 2022-09-07 |
Family
ID=69644668
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511541A Pending JP2021534796A (ja) | 2018-08-31 | 2019-08-30 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
| JP2024081593A Pending JP2024119830A (ja) | 2018-08-31 | 2024-05-20 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
| JP2025266930A Pending JP2026067864A (ja) | 2018-08-31 | 2025-12-19 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024081593A Pending JP2024119830A (ja) | 2018-08-31 | 2024-05-20 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
| JP2025266930A Pending JP2026067864A (ja) | 2018-08-31 | 2025-12-19 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220033826A1 (enExample) |
| EP (1) | EP3843791A4 (enExample) |
| JP (3) | JP2021534796A (enExample) |
| CN (2) | CN120350002A (enExample) |
| AU (1) | AU2019328577A1 (enExample) |
| CA (1) | CA3110563A1 (enExample) |
| IL (2) | IL321380A (enExample) |
| WO (1) | WO2020047476A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL321380A (en) * | 2018-08-31 | 2025-08-01 | Univ Florida | Adeno-associated viral vectors for the treatment of best disease |
| US20220347318A1 (en) * | 2019-09-25 | 2022-11-03 | University Of Utah Research Foundation | Methods and compositions for the expression of constitutively active rap1a from a vmd2 promoter |
| IL295673A (en) * | 2020-02-28 | 2022-10-01 | Univ Pennsylvania | Treatment of autosomal dominant strophin diseases and methods of their evaluation |
| WO2024064608A2 (en) * | 2022-09-20 | 2024-03-28 | Intergalactic Therapeutics, Inc. | Best1 vectors and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050049212A1 (en) * | 2001-10-09 | 2005-03-03 | Arnd Steuernagel | Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| AU2003295600A1 (en) * | 2002-11-14 | 2004-06-15 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| WO2005056761A2 (en) * | 2003-12-05 | 2005-06-23 | Massachusetts Institute Of Technology | REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| JP4543188B2 (ja) * | 2004-03-10 | 2010-09-15 | 学校法人日本医科大学 | ヒトチミジル酸合成酵素に対するＲＮＡｉとして作用するＲＮＡ配列 |
| CN101538569B (zh) * | 2008-08-19 | 2011-07-06 | 香港理工大学深圳研究院 | 抑制人dmt1蛋白的rna、重组体及应用 |
| KR101154538B1 (ko) * | 2009-08-24 | 2012-06-13 | 한국과학기술연구원 | 소뇌에서의 ｇａｂａ 방출 조절제 |
| CN102277434B (zh) * | 2011-07-28 | 2015-11-18 | 上海吉凯基因化学技术有限公司 | 人zfx基因的用途及其相关药物 |
| CN102533982B (zh) * | 2011-12-19 | 2016-01-06 | 上海吉凯基因化学技术有限公司 | 人klf8基因在肿瘤治疗中的新用途 |
| CA2907095C (en) * | 2012-03-16 | 2020-11-03 | The Regents Of The University Of California | A novel rnai molecule delivery platform based on single-sirna and shrna nanocapsules |
| WO2013151665A2 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| US9546366B2 (en) * | 2013-03-14 | 2017-01-17 | Raadysan Biotech, Inc. | Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer |
| JP6707028B2 (ja) * | 2013-12-09 | 2020-06-10 | ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ | 心筋細胞新生におけるｈｉｐｐｏ及びジストロフィン複合体シグナル伝達 |
| GB201322798D0 (en) * | 2013-12-20 | 2014-02-05 | Oxford Biomedica Ltd | Production system |
| US20180346981A1 (en) * | 2014-11-20 | 2018-12-06 | Massachusetts Eye And Ear Infirmary | Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases |
| EP3240612B1 (en) * | 2014-12-30 | 2020-12-23 | Cell Cure Neurosciences Ltd. | Methods of treating retinal diseases |
| CN107287238B (zh) * | 2016-04-11 | 2020-10-16 | 厦门继景生物技术有限责任公司 | 一种基因载体及其用于治疗雷柏氏先天性黑矇2型疾病的基因治疗药物 |
| IL321380A (en) * | 2018-08-31 | 2025-08-01 | Univ Florida | Adeno-associated viral vectors for the treatment of best disease |
-
2019
- 2019-08-30 IL IL321380A patent/IL321380A/en unknown
- 2019-08-30 AU AU2019328577A patent/AU2019328577A1/en active Pending
- 2019-08-30 CA CA3110563A patent/CA3110563A1/en active Pending
- 2019-08-30 CN CN202510424401.8A patent/CN120350002A/zh active Pending
- 2019-08-30 CN CN201980067514.XA patent/CN112839682B/zh active Active
- 2019-08-30 US US17/272,203 patent/US20220033826A1/en active Pending
- 2019-08-30 EP EP19854295.3A patent/EP3843791A4/en active Pending
- 2019-08-30 JP JP2021511541A patent/JP2021534796A/ja active Pending
- 2019-08-30 WO PCT/US2019/049163 patent/WO2020047476A1/en not_active Ceased
-
2021
- 2021-02-24 IL IL281083A patent/IL281083A/en unknown
-
2024
- 2024-05-20 JP JP2024081593A patent/JP2024119830A/ja active Pending
-
2025
- 2025-12-19 JP JP2025266930A patent/JP2026067864A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534796A5 (enExample) | ||
| JP2019519219A5 (enExample) | ||
| JP2024119830A5 (enExample) | ||
| JP2021007394A (ja) | 筋萎縮性側索硬化症（ａｌｓ）を治療する組成物および方法 | |
| JP2015523853A5 (enExample) | ||
| JP2015518710A5 (enExample) | ||
| JP2016522674A5 (enExample) | ||
| HRP20201200T1 (hr) | OLIGONUKLEOTIDNI SPOJEVI ZA CILJANJE HUNTINGTIN mRNK | |
| JP2019519218A5 (enExample) | ||
| JP2016521556A5 (enExample) | ||
| Ruiz et al. | MicroRNA-detargeted mengovirus for oncolytic virotherapy | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| JP2019511216A5 (enExample) | ||
| JP2015518712A5 (enExample) | ||
| JP2015523379A5 (enExample) | ||
| JP2015523855A5 (enExample) | ||
| JP2019520841A5 (enExample) | ||
| JP2015518711A5 (enExample) | ||
| JP2021525531A5 (enExample) | ||
| JP2021513866A5 (enExample) | ||
| JP2022535412A5 (enExample) | ||
| CN113164624B (zh) | 恢复人类快乐木偶综合征中父系ube3a基因表达的组合物和方法 | |
| JP2022501044A5 (enExample) | ||
| CN107893078A (zh) | 靶向突触结合蛋白‑11的siRNA、表达载体和病毒颗粒及其制药应用 | |
| JP2021502978A5 (enExample) |